Fabrication of a Coculture Organoid Model in the Biomimetic Matrix of Alginate to Investigate Breast Cancer Progression in a TAMs-Leading Immune Microenvironment
ACS Applied Materials & Interfaces · 06.03.2024 · 16 (9) · 11275-11288
DOI: 10.1021/acsami.3c17863 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 21.02.2024. Verfasst von Nian-Yuan Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, P. R. China. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Natural Science Foundation of Hubei Province, National Natural Science Foundation of China, Central Hospital of Wuhan.
Abstract (Originalsprache)
The current research models of breast cancer are usually limited in their capacity to recapitulate the tumor microenvironment in vitro. The lack of an extracellular matrix (ECM) oversimplifies cell-cell or cell-ECM cross-talks. Moreover, the lack of tumor-associated macrophages (TAMs), that can comprise up to 50% of some solid neoplasms, poses a major problem for recognizing various hallmarks of cancer. To address these concerns, a type of direct breast cancer cells (BCCs)-TAMs coculture organoid model was well developed by a sequential culture method in this study. Alginate cryogels were fabricated with appropriate physical and mechanical properties to serve as an alternative ECM. Then, our previous experience was leveraged to polarize TAMs inside of the cryogels for creating an in vitro immune microenvironment. The direct coculture significantly enhanced BCCs organoid growth and cancer aggressive phenotypes, including the stemness, migration, ECM remodeling, and cytokine secretion. Furthermore, transcriptomic analysis and protein-protein interaction networks implied certain pathways (PI3K-Akt pathway, MAPK signaling pathway, etc.) and targets (TNF, PPARG, TLR2, etc.) during breast cancer progression in a TAM-leading immune microenvironment. Future studies to advance treatment strategies for BCC patients may benefit from using this facile model to reveal and target the interactions between cancer signaling and the immune microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, P. R. China.
- Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, P. R. China.
ORCID-Profile: Xi-Qiu Liu
Förderung
- Natural Science Foundation of Hubei Province
- National Natural Science Foundation of China
- Central Hospital of Wuhan
- Hubei Provincial Administration of Traditional Chinese Medicine
- Wuhan Outstanding Young Talents Project
Zitieren
APA
Xu, N. Y., Li, J., Wang, M. L., Chen, X. Y., Tang, R., & Liu, X. Q. (2024). Fabrication of a Coculture Organoid Model in the Biomimetic Matrix of Alginate to Investigate Breast Cancer Progression in a TAMs-Leading Immune Microenvironment. ACS Applied Materials & Interfaces, 16(9), 11275-11288. https://doi.org/10.1021/acsami.3c17863
Vancouver
Xu NY, Li J, Wang ML, Chen XY, Tang R, Liu XQ. Fabrication of a Coculture Organoid Model in the Biomimetic Matrix of Alginate to Investigate Breast Cancer Progression in a TAMs-Leading Immune Microenvironment. ACS Applied Materials & Interfaces. 2024;16(9):11275-11288. doi:10.1021/acsami.3c17863
BibTeX
@article{Xu2024,
author = {Xu, Nian-Yuan and Li, Jun and Wang, Mei-Ling and Chen, Xue-Yu and Tang, Ruizhi and Liu, Xi-Qiu},
title = {Fabrication of a Coculture Organoid Model in the Biomimetic Matrix of Alginate to Investigate Breast Cancer Progression in a TAMs-Leading Immune Microenvironment},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
volume = {16},
number = {9},
pages = {11275--11288},
doi = {10.1021/acsami.3c17863}
}
EUVIMED